BioSpace News Archive

BioMidwest

Florida Blue Waives Cost-Sharing for COVID-19 Treatment

Florida Blue, the state’s leading health insurer, announced it will waive cost-sharing through June 1 for its members who must undergo treatment for COVID-19, including in-patient hospital admissions.

March 31, 2020
·
4 min read
Business

Co-Diagnostics, Inc. Reports 2019 Year-End Financial Results and Progress Updates

Co-Diagnostics, Inc. (Nasdaq: CODX), a molecular diagnostics company with a unique, patented platform for the development of molecular diagnostic tests, today announced the filing of their financial results for the fiscal year ending December 31, 2019, as well as updates on the Company’s growth and progress for 2019 and 2020 to date in the following areas:

March 31, 2020
·
8 min read
Policy

Massachusetts Nurses Association Releases March 31 Letter to Governor Baker Opposing New State PPE Guidance and Calling for Stronger Protection and Support for Frontline Healthcare Workers to Combat COVID-19

The MNA is advocating for a consistent approach to COVID-19 statewide within healthcare facilities that upholds the highest personal protective equipment safety standards

March 31, 2020
·
6 min read
Policy

Advisory - Certain Lots of Taro-Zoledronic acid injection drug, used for osteoporosis and Paget’s disease, recalled due to potential presence of particulate matter

Taro Pharmaceuticals Inc. is recalling five lots of Taro-Zoledronic acid injection 5mg/100mL, due to the potential presence of particulate matter.

March 31, 2020
·
2 min read
Abartys Health Introduces PatientLynk 2.0 to Enable Universal Patient Identification, Provide Faster Response for COVID-19 Lab Tests

Abartys Health, a healthcare data solutions company, today announces the launch of its PatientLynk 2.0.

March 31, 2020
·
3 min read
Neteera, the Global Leader in Contact-free Vital Signs Monitoring, Launches Contactless Vital Signs Sensing System for COVID-19 Early Screening and Home Care

As the world grapples with the current COVID-19 (Coronavirus) pandemic, the spotlight has been thrown on the interface between those afflicted by the virus, and the infrastructure delivering essential treatment to those in urgent need.

March 31, 2020
·
2 min read
Deals

Newron AGM Result and Clinical and Business Update

Newron Pharmaceuticals S.p.A., a biopharmaceutical company focused on the development of novel therapies for patients with diseases of the central and peripheral nervous system, announced that its shareholders approved all motions on the agenda of the AGM 2020.

March 31, 2020
·
6 min read
Saxenda® Demonstrated Improvements in BMI and Body Weight in Adolescents With Obesity

Novo Nordisk announced that the New England Journal of Medicine published results of a phase 3 trial evaluating the investigational use of Saxenda® in adolescents with obesity.

March 31, 2020
·
9 min read
Business

IONpath and Bristol Myers Squibb Jointly Author New Laboratory Investigation Article Exploring the Complexities of the Tumor Microenvironment

IONpath, Inc. announces that they have jointly authored with Bristol Myers Squibb an article entitled Multiplexed Ion Beam Imaging for Characterization of the Tumor Microenvironment Across Tumor Types for the Nature journal Laboratory Investigation.

March 31, 2020
·
3 min read
TEPEZZA™ (teprotumumab-trbw) Significantly Reduces Proptosis (Eye Bulging), a Key Marker of Thyroid Eye Disease, Across Patient Subtypes

Data presented as part of ENDO 2020 demonstrates proptosis response regardless of age, gender and smoking status

March 31, 2020
·
8 min read